Visiting Dana-Farber? See our prescreening and mask requirements.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Women with gynecologic cancers and survivors, along with their caregivers and loved ones, gathered on May 4, 2019 for a morning of education, support, and companionship. Below are some highlights from the forum, led by Ursula A. Matulonis, MD, and sponsored by Dana-Farber/Brigham and Women’s Cancer Center's Division of Gynecologic Oncology.
Welcome and Overview of the Division’s Mission, Accomplishments, and Future GoalsUrsula A. Matulonis, MD, welcomes attendees and provides an overview of recent developments.
Developments in the Treatment of Gynecologic CancersSusana M. Campos, MD, MPH, discusses developments in treatment for gynecologic cancers.
Panel 1: Your Treatment TeamMembers of the patient care team discuss various types of support available to patients.
Updates in Patient-Reported Outcomes ResearchAlexi A. Wright, MD, MPH, discusses updates in patient-reported outcomes research.
Panel 2: Clinical Research TeamA team of research nurses discuss clinical trials and answer questions from the audience.
New Patient Appointments